
Join to View Full Profile
4400 Biscayne BoulevardMiami, FL 33137
Phone+1 305-575-4127
Dr. Melnick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Creighton University School of MedicineClass of 1987
Certifications & Licensure
- IL State Medical License 1996 - 2017
Clinical Trials
- A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects Start of enrollment: 2002 Jan 01
- Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis Start of enrollment: 2006 Sep 01
- Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease Start of enrollment: 2008 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 60 citationsUse of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.Stuart M. Sprague, Paul W Crawford, Joel Z. Melnick, Stephen A Strugnell, Shaukat Ali
American Journal of Nephrology. 2016-10-18 - 32 citationsModified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulationMartin Petkovich, Joel Z. Melnick, Jay A. White, Samir P. Tabash, Stephen Strugnell
The Journal of Steroid Biochemistry and Molecular Biology. 2015-04-01 - 1 citationsPosition Statement from ADA/AACE/EASD/TES in Response to a Recently Published Letter to the Editor in The Lancet and an Editorial Addressing the Israeli-Palestinian Fi...Wei Deng, Yile Ren, Xuebing Feng, Genhong Yao, Weiwei Chen
American Journal of Nephrology. 2014-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: